| Serous Cystadenocarcinoma altered in cohorts of …ALTERED_INderived98 of 98show fewer |
|---|
| ← altered in cohorts of | TP53 483 / 603 cases (80 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 455 / 603 cases (75 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM135B 449 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 449 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTRT3 447 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADCY8 446 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AGO2 446 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC34 446 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYNN 446 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTK2 446 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR20 445 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GSDMC 445 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRATD2 445 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC31 445 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRIQ4 445 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTP4A3 445 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASAP1 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRAC1 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMD7 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC62 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC45A4 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TG 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIB1 444 / 603 cases (74 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL22A1 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYRIB 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPPK1 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR160 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNK9 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KHDRBS3 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MECOM 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCRIB 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFAT 443 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN11 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND3 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83H 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQANK1 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK15 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRBP2 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PARP10 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHC3 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKCI 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PUF60 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SKIL 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC7A14 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ST3GAL1 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM71 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRAPPC9 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF623 442 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC166 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCN4 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL14A1 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1D 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFR3A 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRINA 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HGH1 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH1 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OPLAH 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHF20L1 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLEC 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PYCR3 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLA 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATC1 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TIGD5 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TSNARE1 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC5 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZC3H3 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF707 441 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BOP1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYC1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF5A2 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EXOSC4 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GFUS 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPAA1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GSDMD 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HHLA1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ3 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC6 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAFA 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH6 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAPRT 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDRG1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE2 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OC90 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL22L1 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCX 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHARPIN 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SQLE 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNIK 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TONSL 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR97 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF572 440 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADGRB1 439 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP11B2 439 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LY6E 439 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC2A2 439 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC39A4 439 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VPS28 439 / 603 cases (73 %) · ssm · TCGA-OV | — | — | Ovarian Serous Cystadenocarcinoma | 1 | Observed | gdc | graph → |